Tiziana Life Sciences Ltd given nod for second patient to undergo multiple sclerosis treatment
Clinical data from the first patient, having completed three of six months, revealed the treatment was well tolerated by the patient with a...
Kunwar Shailubhai Tanuja Chitnis Drugs Administration Tiziana Life Sciences Ltd Patient Expanded Access Programme Individual Patient Expanded Access
Source: proactiveinvestors.co.uk